What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Biochemistry
Karl Folkers mostly deals with Internal medicine, Endocrinology, Substance P, Stereochemistry and Biochemistry.
The various areas that Karl Folkers examines in his Internal medicine study include Gastroenterology and Cardiology.
His Endocrinology study frequently links to related topics such as Neurotensin.
His studies deal with areas such as Anatomy, Antagonist, Pharmacology and Stimulation as well as Substance P.
The Stereochemistry study combines topics in areas such as Coenzyme Q – cytochrome c reductase and D-4-amino-3-Isoxazolidone.
Biochemistry is frequently linked to Isolation in his study.
His most cited work include:
- The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. (461 citations)
- Crystalline Vitamin B12. (407 citations)
- A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. (396 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Stereochemistry, Endocrinology, Biochemistry and Coenzyme Q – cytochrome c reductase.
His biological study spans a wide range of topics, including Gastroenterology and Cardiology.
His study in Stereochemistry is interdisciplinary in nature, drawing from both Amino acid and Organic chemistry.
He has researched Endocrinology in several fields, including Receptor and In vitro.
His study in Cofactor, Enzyme, Mitochondrion, Vitamin B12 and Biosynthesis are all subfields of Biochemistry.
Karl Folkers interconnects Antagonist and Pharmacology in the investigation of issues within Substance P.
He most often published in these fields:
- Internal medicine (27.17%)
- Stereochemistry (24.00%)
- Endocrinology (22.76%)
What were the highlights of his more recent work (between 1978-2016)?
- Internal medicine (27.17%)
- Endocrinology (22.76%)
- Coenzyme Q10 (12.69%)
In recent papers he was focusing on the following fields of study:
Karl Folkers focuses on Internal medicine, Endocrinology, Coenzyme Q10, Substance P and Stereochemistry.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Surgery and Cardiology.
His work on Receptor expands to the thematically related Endocrinology.
His Coenzyme Q10 research is multidisciplinary, relying on both Cancer, Coenzyme Q – cytochrome c reductase, Antioxidant, Immunology and Disease.
His Substance P research incorporates themes from Antagonist, Pharmacology and Stimulation.
The study incorporates disciplines such as Amino acid, Peptide synthesis and Biological activity in addition to Stereochemistry.
Between 1978 and 2016, his most popular works were:
- A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. (396 citations)
- Lovastatin decreases coenzyme Q levels in humans. (377 citations)
- A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation. (236 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Biochemistry
His primary scientific interests are in Internal medicine, Endocrinology, Substance P, Coenzyme Q10 and Pharmacology.
His Internal medicine research includes elements of Gastroenterology and Cardiology.
His Substance p antagonist research extends to Endocrinology, which is thematically connected.
His Substance P research incorporates themes from Antagonist and Stimulation.
As a part of the same scientific family, Karl Folkers mostly works in the field of Coenzyme Q10, focusing on Chemotherapy and, on occasion, Opportunistic infection and Constitutional symptoms.
As part of one scientific family, Karl Folkers deals mainly with the area of Pharmacology, narrowing it down to issues related to the Anesthesia, and often Galanin and Neuropeptide.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
